Antipodes Partners LTD Procept Bio Robotics Corp Transaction History
Antipodes Partners LTD
- $3.16 Billion
- Q1 2025
A detailed history of Antipodes Partners LTD transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Antipodes Partners LTD holds 507 shares of PRCT stock, worth $30,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
507Holding current value
$30,060% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PRCT
# of Institutions
300Shares Held
41.9MCall Options Held
293KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.13MShares$304 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$207 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY2.14MShares$127 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD1.42MShares$83.9 Million0.05% of portfolio
-
State Street Corp Boston, MA1.19MShares$70.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.64B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...